Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine

BACKGROUND: Gait impairment is common in multiple sclerosis (MS) and negatively impacts patients’ health-related quality of life (HRQoL). Prolonged-release fampridine (PR-fam) improves walking speed, but it is unclear which walking measures are the most suitable for identifying treatment response. O...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Neurol Disord
Egile Nagusiak: Sola-Valls, Núria, Blanco, Yolanda, Sepúlveda, María, Llufriu, Sara, Martínez-Lapiscina, Elena H., Zubizarreta, Irati, Pulido-Valdeolivas, Irene, Montejo, Carmen, Villoslada, Pablo, Saiz, Albert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6024337/
https://ncbi.nlm.nih.gov/pubmed/29977342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418780007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak